JD Health International (FRA:8ZN) Cyclically Adjusted PS Ratio: (As of Aug. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8ZN JD Health International Inc FRA:8ZN
92 GF Score
Price €4.24
GF Value €6.34
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is JD Health International Cyclically Adjusted PS Ratio?

JD Health International does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.

Shiller PE for Stocks: The True Measure of Stock Valuation


JD Health International  (FRA:8ZN) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


JD Health International Cyclically Adjusted PS Ratio Related Terms


JD Health International Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for JD Health International's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JD Health International Cyclically Adjusted PS Ratio Chart

JD Health International Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

JD Health International Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

JD Health International Cyclically Adjusted PS Ratio Competitor Comparison

For the Pharmaceutical Retailers subindustry, JD Health International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JD Health International Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where JD Health International's Cyclically Adjusted PS Ratio falls into.


FRA:8ZN
92GF Score
JD Health International Inc FRA:8ZN
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JD Health International Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

JD Health International does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.

Is JD Health International (FRA:8ZN) Overvalued in 2026?

Based on GuruFocus' analysis, JD Health International stock appears to be undervalued. The current stock price of €4.24 is trading 33.1% below its estimated GF Value™ of €6.34. GuruFocus considers JD Health International to be Significantly Undervalued.

Key valuation signals for FRA:8ZN:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €6.34 vs. price of €4.24 (33.1% below fair value)
  • GF Score™: 92/100 with 1 warning sign

No single metric tells the full story. See the FRA:8ZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JD Health International Business Description

Address No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
92GF Score

Get the complete analysis for FRA:8ZN

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.24
Price
€6.34
GF Value